Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16258101

J. Clin. Oncol. 2005 Nov 1 23 31 8033-40

Download in:

View as

Triples

General Info

PMID
16258101